The South Australian immunoGENomics Cancer Institute (SAiGENCI) is an independent cancer-focused medical research institute located in South Australia; focusing on cancer research and clinical trials, which will include new cutting-edge technologies in immunotherapies and genomics.
Headquarter Australia |
Countries of operation Australia |
Year founded 2020 (4 years) |
Funding status Private |
Company type SME |
Group Head
Research Development Manager
Senior Postdoctoral Researcher